MiR-802 alleviates lipopolysaccharide-induced acute lung injury by targeting Peli2

被引：0
|
作者：
Qinghai You
Jinmei Wang
Dan Jia
Lijuan Jiang
Yuanmin Chang
Wenmei Li
机构：
[1] The First Affiliated Hospital of Anhui Medical University,Department of Respiratory and Critical Care Medicine
[2] The Affiliated Hospital of Jining Medical College,Department of Respiratory Medicine
[3] The First Affiliated Hospital of Huzhou Teachers College,Department of Respiratory Medicine
[4] The Chest Hospital of Anhui Province,Department of Respiratory Medicine
[5] The First Affiliated Hospital of Anhui Medical University,Department of Respiratory and Critical Care Medicine
来源：
Inflammation Research | 2020年 / 69卷
关键词：
Acute respiratory distress syndrome; miR802; Sepsis; Peli2; Lung injury;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 85
页数：10
相关论文
共 50 条
  • [21] Biocompatible N-acetyl-nanoconstruct alleviates lipopolysaccharide-induced acute lung injury in vivo
    Kim, Seongchan
    Kim, Shin Young
    Rho, Seung Joon
    Kim, Seung Hoon
    Song, So Hyang
    Kim, Chi Hong
    Lee, Hyojin
    Kim, Sung Kyoung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] A synthetic chalcone derivative, compound 39, alleviates lipopolysaccharide-induced acute lung injury in mice
    Lin, Yuting
    Lu, Qingdi
    Chen, Chaolei
    Wang, Beibei
    Guo, Lisha
    Xie, Jingwen
    Chen, Chengshui
    Huang, Lili
    Dong, Li
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 891
  • [23] Biocompatible N-acetyl-nanoconstruct alleviates lipopolysaccharide-induced acute lung injury in vivo
    Seongchan Kim
    Shin Young Kim
    Seung Joon Rho
    Seung Hoon Kim
    So Hyang Song
    Chi Hong Kim
    Hyojin Lee
    Sung Kyoung Kim
    Scientific Reports, 11
  • [24] The SMAC mimetic birinapant alleviates lipopolysaccharide-induced acute lung injury by inhibiting MAPK signaling
    Hu, Hui
    Ma, Man
    Li, Tao
    Shi, Li
    Li, Peizhi
    IMMUNOLOGY LETTERS, 2023, 264 : 31 - 35
  • [25] Fexofenadine protects against lipopolysaccharide-induced acute lung injury by targeting cytosolic phospholipase A2
    Chen, Yuehong
    Liu, Huan
    Tian, Yunru
    Luo, Zhongling
    Ran, Jingjing
    Miao, Zhiyong
    Zhang, Qiuping
    Yin, Geng
    Xie, Qibing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116
  • [26] Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
    Ya-li Zhang
    Wen-xin Zhang
    Jue-qian Yan
    Ye-lin Tang
    Wen-jing Jia
    Zheng-wei Xu
    Ming-jiang Xu
    Nipon Chattipakorn
    Yi Wang
    Jian-peng Feng
    Zhi-guo Liu
    Guang Liang
    Acta Pharmacologica Sinica, 2022, 43 : 76 - 85
  • [27] Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
    Zhang, Ya-li
    Zhang, Wen-xin
    Yan, Jue-qian
    Tang, Ye-lin
    Jia, Wen-jing
    Xu, Zheng-wei
    Xu, Ming-jiang
    Chattipakorn, Nipon
    Wang, Yi
    Feng, Jian-peng
    Liu, Zhi-guo
    Liang, Guang
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (01) : 76 - 85
  • [28] The Activity Of Transglutaminase-2 In Lipopolysaccharide-induced Acute Lung Injury
    Kim, J.
    Yoon, D.
    Jung, K.
    Kim, H.
    Ha, E.
    Lee, K.
    Hur, G.
    Lee, S.
    Shin, C.
    Shim, J.
    In, K.
    Kang, K.
    Yoo, S.
    Suh, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [29] Effects Of Simvastatin In Lipopolysaccharide-Induced Acute Lung Injury
    Sarmiento, K. F.
    Cowan, M.
    King, D.
    Scharf, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [30] Transcriptional profiling of lipopolysaccharide-induced acute lung injury
    Jeyaseelan, S
    Chu, HW
    Young, SK
    Worthen, GS
    INFECTION AND IMMUNITY, 2004, 72 (12) : 7247 - 7256
12345